Chicago Partners Investment Group’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-174
| Closed | -$1K | – | 1067 |
|
|
2018
Q3 | $1K | Hold |
174
| – | – | ﹤0.01% | 1055 |
|
|
2018
Q2 | $1K | Hold |
174
| – | – | ﹤0.01% | 946 |
|
|
2018
Q1 | $1K | Hold |
174
| – | – | ﹤0.01% | 915 |
|
|
2017
Q4 | $1K | Hold |
174
| – | – | ﹤0.01% | 866 |
|
|
2017
Q3 | $1K | Buy |
+174
| New | +$1K | ﹤0.01% | 946 |
|
|
2017
Q2 | – | Sell |
-174
| Closed | -$2K | – | 844 |
|
|
2017
Q1 | $2K | Hold |
174
| – | – | ﹤0.01% | 529 |
|
|
2016
Q4 | $2K | Hold |
174
| – | – | ﹤0.01% | 515 |
|
|
2016
Q3 | $3K | Hold |
174
| – | – | ﹤0.01% | 476 |
|
|
2016
Q2 | $2K | Hold |
174
| – | – | ﹤0.01% | 430 |
|
|
2016
Q1 | $3K | Hold |
174
| – | – | ﹤0.01% | 414 |
|
|
2015
Q4 | $5K | Hold |
174
| – | – | ﹤0.01% | 449 |
|
|
2015
Q3 | $8K | Hold |
174
| – | – | ﹤0.01% | 358 |
|
|
2015
Q2 | $6K | Buy |
174
+28
| +19% | +$966 | ﹤0.01% | 390 |
|
|
2015
Q1 | $6K | Sell |
146
-28
| -16% | -$1.15K | ﹤0.01% | 417 |
|
|
2014
Q4 | $7K | Buy |
+174
| New | +$7K | ﹤0.01% | 416 |
|